FDA recommends screening all donated blood for Zika

The U.S. Food and Drug Administration (FDA) issued revised guidance recommending universal testing of donated Whole Blood and blood components for Zika virus in the U.S. and its territories. This updates earlier guidance recommending Zika screening only in areas with active Zika transmission. The FDA is updating its guidance after consideration of all available scientific evidence, in consultation with other public health agencies, and taking into consideration the potential serious health consequences of Zika virus infection to pregnant women and children born to women exposed to Zika virus during pregnancy. Read the FDA news release.